OGT Monoclonal antibody 66823-1-Ig proteintech

$149.00
In stock
SKU
66823-1-Ig
Catalog No.SizePrice (USD)
66823-1-IG-20UL20 μL$149.00
66823-1-IG-150UL150 μL$449.00
66823-1-IG-10X150UL1.5 mL (10 x 150 μL vials)$3,592.00
Catalog Number66823-1-Ig
SynonymsFLJ23071, HRNT1, OGT
HostMouse
ReactivityHuman, mouse, rat, pig and More (1)
Reactivityhuman, mouse, rat, pig
FormLiquid
FormulationPBS, Azide, Glycerol
ApplicationsWB, IHC, IF/ICC, ELISA
Host / IsotypeMouse / IgG2a
Tested Applications — Positive WB detected inHeLa cells, HEK-293 cells, HSC-T6 cells, NIH/3T3 cells, pig brain tissue, rat brain tissue, mouse brain tissue
Tested Applications — Positive IHC detected inhuman lung cancer tissue, human colon cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Tested Applications — Positive IF/ICC detected inHepG2 cells
Recommended Dilutions — Western Blot (WB)WB : 1:5000-1:50000
Recommended Dilutions — Immunohistochemistry (IHC)IHC : 1:250-1:1000
Recommended Dilutions — Immunofluorescence (IF)/ICCIF/ICC : 1:200-1:800
Positive WB detected inHeLa cells, HEK-293 cells, HSC-T6 cells, NIH/3T3 cells, pig brain tissue, rat brain tissue, mouse brain tissue
Positive IHC detected inhuman lung cancer tissue, human colon cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF/ICC detected inHepG2 cells
Western Blot (WB)WB : 1:5000-1:50000
Immunohistochemistry (IHC)IHC : 1:250-1:1000
Immunofluorescence (IF)/ICCIF/ICC : 1:200-1:800
Tested ReactivityHuman, mouse, rat, pig
Cited Reactivityhuman, mouse, rat
ClassMonoclonal
TypeAntibody
ImmunogenCatNo: Ag28402 Product name: Recombinant human OGT protein Source: e coli. -derived, PET28a Tag: 6*His Domain: 1-400 aa of BC014434 Sequence: MASSVGNVADSTGLAELAHREYQAGDFEAAERHCMQLWRQEPDNTGVLLLLSSIHFQCRRLDRSAHFSTLAIKQNPLLAEAYSNLGNVYKERGQLQEAIEHYRHALRLKPDFIDGYINLAAALVAAGDMEGAVQAYVSALQYNPDLYCVRSDLGNLLKALGRLEEAKACYLKAIETQPNFAVAWSNLGCVFNAQGEIWLAIHHFEKAVTLDPNFLDAYINLGNVLKEARIFDRAVAAYLRALSLSPNHAVVHGNLACVYYEQGLIDLAIDTYRRAIELQPHFPDAYCNLANALKEKGSVAEAEDCYNTALRLCPTHADSLNNLANIKREQGNIEEAVRLYRKALEVFPEFAAAHSNLASVLQQQGKLQEALMHYKEAIRISPTFADAYSNMGNTLKEMQD Predict reactive species
Full NameO-linked N-acetylglucosamine (GlcNAc) transferase (UDP-N-acetylglucosamine:polypeptide-N-acetylglucosaminyl transferase)
Calculated Molecular Weight1046 aa, 117 kDa
Observed Molecular Weight110 kDa
GenBank Accession NumberBC014434
Gene SymbolOGT
Gene ID (NCBI)8473
RRIDAB_2882166
ConjugateUnconjugated
Purification MethodProtein A purification
UNIPROT IDO15294
Storage BufferPBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20 o C storage. 20ul sizes contain 0.1% BSA.
IF protocol for OGT antibody 66823-1-IgDownload protocol
IHC protocol for OGT antibody 66823-1-IgDownload protocol
WB protocol for OGT antibody 66823-1-IgDownload protocol
humanWB World J Gastrointest Oncol Senegenin suppresses hepatocellular carcinoma by regulating O-GlcNAcylation Authors - Xiang Zhang View Article
Citations18
DilutionsWB : 1:5000-1:50000 IHC : 1:250-1:1000 IF/ICC : 1:200-1:800
IsotypeIgG2a
ClonalityMonoclonal
Clone Number2B2A6
ConjugationUnconjugated

O-linked N-acetylglucosamine transferase (OGT) catalyzes the attachment of N-acetylglucosamine (GlcNAc) monosaccharides to the hydroxyl group of serine or threonine residues of numerous nuclear and cytoplasmic proteins and may play important roles in a large number of diverse intracellular processes ranging from translational control, transcription, transcriptional repression, INS resistance and regulation of the cell cycle. It exists as a heterotrimeric complex with two 110 kDa and one 70 kDa subunits. Recent studies have shown that O-GlcNAcylation plays essential roles in cancer formation and progression. O-GlcNAcylation as well as OGT expression was found to be significantly elevated in the cancer tissues. Protocols Product Specific Protocols IF protocol for OGT antibody 66823-1-Ig Download protocol IHC protocol for OGT antibody 66823-1-Ig Download protocol WB protocol for OGT antibody 66823-1-Ig Download protocol Standard Protocols Click here to view our Standard Protocols

Publications

  1. LIMA1 O-GlcNAcylation Promotes Hepatic Lipid Deposition through Inducing β-catenin-Regulated FASn Expression in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Journal: Adv Sci (Weinh) | Authors: Fuji Yang | Species: human | Application: WB,IF
  2. FOXA1 O-GlcNAcylation-mediated transcriptional switch governs metastasis capacity in breast cancer
    Journal: Sci Adv | Authors: Yajie Liu KD Validated | Species: human | Application: WB
  3. O-GlcNAcylation of hexokinase 2 modulates mitochondrial dynamics and enhances the progression of lung cancer
    Journal: Mol Cell Biochem | Authors: S I Panpan | Species: human | Application: WB,IHC
  4. Histone methyltransferase Dot1L recruits O-GlcNAc transferase to target chromatin sites to regulate histone O-GlcNAcylation.
    Journal: J Biol Chem | Authors: Bo Xu | Species: human | Application: WB
  5. Senegenin suppresses hepatocellular carcinoma by regulating O-GlcNAcylation
    Journal: World J Gastrointest Oncol | Authors: Xiang Zhang | Species: human | Application: WB
  6. ZNF263-NuRD-mediated repression of STAT1 curtails MHC-I antigen presentation and IFN-γ efficacy in prostate cancer
    Journal: Proc Natl Acad Sci U S A | Authors: Han Guan | Application: WB
  7. Chromatin-associated OGT promotes the malignant progression of hepatocellular carcinoma by activating ZNF263
    Journal: Oncogene | Authors: Lingyan Wang | Species: human,mouse | Application: WB,IHC
  8. OGT deficiency in vascular smooth muscle orchestrates foam cell formation and PANoptosis during atherosclerotic progression.
    Journal: Atherosclerosis | Authors: Boao Liu | Species: mouse, rat | Application: WB,IHC,IF
  9. O-GlcNAcylation promotes topoisomerase IIα catalytic activity in breast cancer chemoresistance
    Journal: EMBO Rep | Authors: Yangzhi Liu
  10. Hexosamine Pathway Disruption by GFPT1 Loss Drives Coordinated Defects in Glycosylation, Autophagy, and Trafficking.
    Journal: Biomolecules | Authors: Stephen H. Holland
  11. A Deficiency in Glutamine-Fructose-6-Phosphate Transaminase 1 (Gfpt1) in Skeletal Muscle Results in Reduced Glycosylation of the Delta Subunit of the Nicotinic Acetylcholine Receptor (AChRδ)
    Journal: Biomolecules | Authors: Stephen Henry Holland | Species: mouse | Application: WB
  12. High-Glucose Microenvironment Accelerates Malignant Progression Via O-GlcNAcylation in Oral Squamous Cell Carcinoma.
    Journal: Int Dent J | Authors: Zhuang Zhu | Species: human | Application: WB,IHC
  13. O-GlcNAcylation licenses RNF166 to degrade the M protein of porcine coronaviruses.
    Journal: PLoS Pathog | Authors: Runhui Qiu
  14. Astragalus Polysaccharide Enhances O-GlcNAcylation Through OGT to Improve Intervertebral Disc Degeneration in Rats.
    Journal: J Cell Mol Med | Authors: Hao Tan | Species: rat | Application: WB
  15. O-GlcNAcylation of hexokinase 2 modulates mitochondrial dynamics and enhances the progression of lung cancer
    Journal: Mol Cell Biochem | Authors: S I Panpan | Species: human | Application: WB,IHC
  16. Histone methyltransferase Dot1L recruits O-GlcNAc transferase to target chromatin sites to regulate histone O-GlcNAcylation.
    Journal: J Biol Chem | Authors: Bo Xu | Species: human | Application: WB
  17. Galactose treatment rescues neuromuscular junction transmission in glutamine-fructose-6-phosphate transaminase 1 (Gfpt1) deficient mice.
    Journal: Hum Mol Genet | Authors: Stephen Henry Holland | Species: mouse | Application: WB
  18. Senegenin suppresses hepatocellular carcinoma by regulating O-GlcNAcylation
    Journal: World J Gastrointest Oncol | Authors: Xiang Zhang | Species: human | Application: WB

Reviews

Write Your Own Review
You're reviewing:OGT Monoclonal antibody 66823-1-Ig proteintech
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.